ADDvise Group Inkomsten in het verleden
Verleden criteriumcontroles 2/6
ADDvise Group has been growing earnings at an average annual rate of 58.4%, while the Medical Equipment industry saw earnings growing at 21.2% annually. Revenues have been growing at an average rate of 37% per year. ADDvise Group's return on equity is 14.6%, and it has net margins of 7%.
Belangrijke informatie
58.4%
Groei van de winst
50.0%
Groei van de winst per aandeel
Medical Equipment Groei van de industrie | 6.2% |
Inkomstengroei | 37.0% |
Rendement op eigen vermogen | 14.6% |
Nettomarge | 7.0% |
Volgende winstupdate | 20 Feb 2025 |
Recente prestatie-updates uit het verleden
Recent updates
ADDvise Group AB (publ) Just Missed Revenue By 5.6%: Here's What Analysts Think Will Happen Next
Oct 27ADDvise Group AB (publ)'s (STO:ADDV A) 26% Dip In Price Shows Sentiment Is Matching Earnings
Oct 02Analysts Have Lowered Expectations For ADDvise Group AB (publ) (STO:ADDV A) After Its Latest Results
Jul 21ADDvise Group AB (publ) (STO:ADDV A) Shares Could Be 45% Below Their Intrinsic Value Estimate
Jun 27ADDvise Group AB (publ)'s (STO:ADDV A) 28% Cheaper Price Remains In Tune With Earnings
Feb 23With EPS Growth And More, ADDvise Group (STO:ADDV A) Makes An Interesting Case
Nov 06Here's Why ADDvise Group (STO:ADDV A) Has Caught The Eye Of Investors
Jun 10Here's Why ADDvise Group (STO:ADDV A) Can Manage Its Debt Responsibly
May 23Is ADDvise Group AB (publ) (STO:ADDV A) Trading At A 43% Discount?
May 05Is ADDvise Group (STO:ADDV A) A Risky Investment?
Jan 17Need To Know: Analysts Are Much More Bullish On ADDvise Group AB (publ) (STO:ADDV A) Revenues
Nov 08ADDvise Group (STO:ADDV A) Ticks All The Boxes When It Comes To Earnings Growth
Oct 21Does ADDvise Group (STO:ADDV A) Have A Healthy Balance Sheet?
Sep 25ADDvise Group AB (publ) Just Beat EPS By 69%: Here's What Analysts Think Will Happen Next
Jul 26Opbrengsten en kosten
Hoe ADDvise Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 24 | 1,634 | 114 | 566 | 0 |
30 Jun 24 | 1,550 | 138 | 543 | 0 |
31 Mar 24 | 1,483 | 111 | 510 | 0 |
31 Dec 23 | 1,379 | 104 | 484 | 0 |
30 Sep 23 | 1,302 | 102 | 457 | 0 |
30 Jun 23 | 1,218 | 101 | 449 | 0 |
31 Mar 23 | 1,105 | 117 | 441 | 0 |
31 Dec 22 | 959 | 81 | 393 | 0 |
30 Sep 22 | 793 | 55 | 330 | 0 |
30 Jun 22 | 660 | 19 | 266 | 0 |
31 Mar 22 | 545 | 0 | 196 | 0 |
31 Dec 21 | 469 | 3 | 160 | 0 |
30 Sep 21 | 410 | 7 | 133 | 0 |
30 Jun 21 | 380 | 11 | 115 | 0 |
31 Mar 21 | 364 | 20 | 103 | 0 |
31 Dec 20 | 359 | 15 | 103 | 0 |
30 Sep 20 | 365 | 17 | 107 | 0 |
30 Jun 20 | 369 | 12 | 109 | 0 |
31 Mar 20 | 360 | 2 | 114 | 0 |
31 Dec 19 | 354 | 4 | 109 | 0 |
30 Sep 19 | 325 | 0 | 104 | 0 |
30 Jun 19 | 306 | -2 | 102 | 0 |
31 Mar 19 | 280 | -1 | 96 | 0 |
31 Dec 18 | 271 | -1 | 96 | 0 |
30 Sep 18 | 260 | -7 | 96 | 0 |
30 Jun 18 | 248 | -7 | 92 | 0 |
31 Mar 18 | 250 | -5 | 91 | 0 |
31 Dec 17 | 244 | -6 | 87 | 0 |
30 Sep 17 | 235 | -3 | 80 | 0 |
30 Jun 17 | 229 | 1 | 76 | 0 |
31 Mar 17 | 214 | 6 | 73 | 0 |
31 Dec 16 | 198 | 0 | 73 | 0 |
30 Sep 16 | 183 | -6 | 75 | 0 |
30 Jun 16 | 173 | -13 | 78 | 0 |
31 Mar 16 | 156 | -18 | 74 | 0 |
31 Dec 15 | 151 | -11 | 70 | 0 |
30 Sep 15 | 160 | -8 | 70 | 0 |
30 Jun 15 | 154 | -4 | 63 | 0 |
31 Mar 15 | 151 | -4 | 61 | 0 |
31 Dec 14 | 144 | -5 | 58 | 0 |
30 Sep 14 | 138 | -6 | 54 | 0 |
30 Jun 14 | 137 | -4 | 50 | 0 |
31 Mar 14 | 133 | -3 | 49 | 0 |
31 Dec 13 | 125 | -4 | 48 | 0 |
Kwaliteitswinsten: ADDV A has high quality earnings.
Groeiende winstmarge: ADDV A's current net profit margins (7%) are lower than last year (7.8%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: ADDV A has become profitable over the past 5 years, growing earnings by 58.4% per year.
Versnelling van de groei: ADDV A's earnings growth over the past year (12.5%) is below its 5-year average (58.4% per year).
Winst versus industrie: ADDV A earnings growth over the past year (12.5%) did not outperform the Medical Equipment industry 28.2%.
Rendement op eigen vermogen
Hoge ROE: ADDV A's Return on Equity (14.6%) is considered low.